A phase I trial of GKT 137831 for diabetic nephropathy in healthy volunteers

Trial Profile

A phase I trial of GKT 137831 for diabetic nephropathy in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Nov 2012

At a glance

  • Drugs GKT 831 (Primary)
  • Indications Diabetic nephropathies
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 02 Nov 2012 Results have been reported in a Gekyotex media release.
    • 02 Nov 2012 Status changed from active, no longer recruiting to completed based on information reported in a Genkyotex media release.
    • 02 Nov 2012 Results have been presented at Kidney Week 2012, the annual meeting of the American Society of Nephrology, according to a Genkyotex media release. Results were also summarised in the media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top